IDU Healthcare HIV Management

MEDICAL ADVOCATES IDUs
		HIV Infection/Diseases General Reports Drug Regimens Post-Exposure Prophylaxis Hemodialysis HIV/HBV Women HIV/HCV Nutrition/Malnutrition HIV/TB National Challenges Pathogenesis Transmission Prevention Testing/Monitoring HIV Sequelae Therapeutic Strategies

IDU Disease Main Page Main New and Noteworthy Home Page

Last Update: December 01, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports

Journal Papers, Abstracts, and Commentaries

High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.
Zule WA, Bobashev G.
Drug Alcohol Depend. 2008 Nov 10.
Abstract

Analysis of the Effects of Injecting Drug Use and HIV-1 Infection on 18F-FDG PET Brain Metabolism.
Georgiou MF, Gonenc A, Waldrop-Valverde D, et al
J Nucl Med. 2008 Nov 7.
Abstract

HIV Seropositivity Predicts Longer Duration of Stay and Rehospitalization Among Nonbacteremic
Febrile Injection Drug Users With Skin and Soft Tissue Infections.
Hsieh YH, Rothman RE, Bartlett JG, et al
J Acquir Immune Defic Syndr. 2008 Oct 16.
Abstract

Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and
receiving highly active antiretroviral therapy (HAART).
Michel L, Giorgi R, Villes V, et al
Drug Alcohol Depend. 2008 Sep 5.
Abstract

Setting targets for universal access to HIV prevention, treatment and care for injecting drug
users (IDUs): towards consensus and improved guidance.
Donoghoe MC, Verster A, Pervilhac C, Williams P.
Int J Drug Policy. 2008 Apr;19 Suppl 1:S5-14.
Abstract

Are feelings of responsibility to limit the sexual transmission of HIV associated with safer sex
among HIV-positive injection drug users?
Latka MH, Mizuno Y, Wu Y, et al
J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S88-95.
Abstract

Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV
transmission and increase access to care and adherence to HIV medications among
HIV-seropositive injection drug users.
Purcell DW, Latka MH, Metsch LR, et al
J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S35-47.
Abstract

Rethinking Approaches to Risk Reduction for Injection Drug Users: Differences in Drug
Type Affect Risk for HIV and Hepatitis C Virus Infection Through Drug-Injecting Networks.
De P, Cox J, Boivin JF, Platt RW, Jolly AM .
J Acquir Immune Defic Syndr. 2007 Aug 23;
Abstract

Injection Drug Users' Strategies to Manage Perceptions of Personal Risk: How Do IDUs See
HIV as Having Affected Them?
Smith KC, Lillie TL, Latkin C. |
AIDS Educ Prev. 2007 Jun;19(3):245-57.
Abstract

The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving
treatment for HIV in a directly observed therapy program.
Raffa JD, Grebely J, Tossonian H, et al.
Drug Alcohol Depend. 2007 Mar 22;
Abstract

The Effect of Acids on the Survival of HIV During Drug Injection.
Heimer R, Kinzly ML, He H, Abdala N.
J Acquir Immune Defic Syndr. 2007 Mar 8;
Abstract

A Prognostic Model for HIV Seroconversion Among Injection Drug Users as a Tool for
Stratification in Clinical Trials.
Boileau C, Bruneau J, Al-Nachawati H, et al
J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):489-495.
Abstract

Access to highly active antiretroviral therapy for injection drug users: adherence, resistance,
and death.
Vlahov D, Celentano DD.
Cad Saude Publica. 2006 Apr;22(4):705-718.
Abstract

FULL-TEXT PDF ARTICLE
Using Standardized Methods for Research on HIV and Injecting Drug Use in Developing/Transitional
Countries: Case Study from the WHO Drug Injection Study.
Des Jarlais DD, Perlis TE, Stimson GV, Poznyak V.
BMC Public Health. 2006 Mar 2;6(1):54
Paper

Coinfection With HIV-1 and Human T-Cell Lymphotropic Virus Type II in Intravenous Drug Users
Is Associated With Delayed Progression to AIDS.
Turci M, Pilotti E, Ronzi P, Magnani G
J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):100-106.
Abstract

The Impact of Sex Partners' HIV Status on HIV Seroconversion in a Prospective Cohort of Injection
Drug Users.
Kerr T, Stoltz JA, Strathdee S, et al
JJ Acquir Immune Defic Syndr 2006 Jan 1;41(1):119-123.
Abstract

The effect of HIV infection on overdose mortality.
Wang C, Vlahov D, Galai N, et al
AIDS. 2005 Jun 10;19(9):935-42
Abstract

If I Didn't Have HIV, I'd Be Dead Now: Illness Narratives of Drug Users Living With HIV/AIDS.
Mosack KE, Abbott M, Singer M
Qual Health Res. 2005 May;15(5):586-605.
Abstract

Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected
Injection Drug Users.
Ding L, Landon BE, Wilson IB, et al
Arch Intern Med. 2005 Mar 28;165(6):618-23.
Abstract

The Effect of RANTES Chemokine Genetic Variants on Early HIV-1 Plasma RNA Among
African American Injection Drug Users.
Duggal P, Winkler CA, An P, et al
Acquir Immune Defic Syndr. 2005 Apr 15;38(5):584-589.
Abstract

Body Habitus in a Cohort of HIV-Seropositive and HIV-Seronegative Injection Drug Users.
Smit E, Semba RD, Pilibosian E,
AIDS Patient Care STDS. 2005 Jan;19(1):19-30
Abstract

Prognostic Factors for Survival Differ According to CD4+ Cell Count Among HIV-Infected
Injection Drug Users: Pre-HAART and HAART Eras.
Galai N, Vlahov D, Bareta JC,et al
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):74-81.
Abstract

Baseline self-perceived risk of HIV infection independently predicts the rate of HIV
seroconversion in a prospective cohort of injection drug users.
Wood E, Li K, Miller CL, Hogg RS, et al|
Int J Epidemiol. 2004 Nov 23;
Abstract

Positive and Negative Consequences of HIV Disclosure Among Seropositive Injection
Drug Users.
Parsons JT, Vanora J, Missildine W, et al
AIDS Educ Prev. 2004 Oct;16(5):459-75.
Abstract

Gender differences in progression to AIDS and death from HIV seroconversion in
a cohort of injecting dug users from 1986 to 2001.
de la Hera MG, Ferreros I, Del Amo J, et al
J Epidemiol Community Health. 2004 Nov;58(11):944-50.
Abstract

An HIV Prevalence-based Model for Estimating Urban Risk Populations of Injection Drug
Users nd Men Who Have Sex with Men.
Lieb S, Friedman SR, Zeni MB, Chitwood DD,
J Urban Health. 2004 Sep;81(3):401-15.
Abstract

Injection drug use and crack cocaine smoking: independent and dual risk behaviors f
or HIV infection.
McCoy CB, Lai S, Metsch LR, et al
Ann Epidemiol. 2004 Sep;14(8):535-42.
Abstract

HIV-1 co/super-infection in intravenous drug users.
The Swiss HIV Cohort Study.
AIDS. 2004 Jul 2;18(10):1413-1421.
Abstract

HIV-Positive Injection Drug Users Who Leave the Hospital Against Medical Advice:
The Mitigating Role of Methadone and Social Support.
Chan AC, Palepu A, Guh DP, et al
J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):56-59.
Abstract

HIV/HBV Coinfection

Journal Papers, Abstracts, and Commentaries

Preliminary research on the co-infection of human immunodeficiency virus and hepatitis
virus in intravenous drug users.
Wu N, Li D, Zhu B, Zou W.
Chin Med J (Engl). 2003 Sep;116(9):1318-1320
Abstract

HIV/TB Coinfection

Journal Papers, Abstracts, and Commentaries

Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services.
Sylla L, Bruce RD, Kamarulzaman A, Altice FL.
Int J Drug Policy. 2007 Aug;18(4):306-12.
Abstract

Pathogenesis

Journal Papers, Abstracts, and Commentaries

HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with
maintenance of seronegativity.
Makedonas G, Bruneau J, Lin H, et al.
AIDS 2002 Aug 16;16(12):1595-602
Abstract

Transmission

Journal Papers, Abstracts, and Commentaries

HIV transmission as a result of drug market violence: a case report.
Small W, Kerr T, Wood E.
Confl Health. 2008 Jul 18;2(1):8.
Abstract

Detection of HIV-1 in Injection Paraphernalia: Risk in an Era of Heightened Awareness.
Page JB, Shapshak P, Duran EM, et al
AIDS Patient Care STDS. 2006 Aug;20(8):576-85.
Abstract

Requiring Help Injecting Independently Predicts Incident HIV Infection Among
Injection Drug Users.
O'connell JM, Kerr T, Li K, et al
J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):83-88.
Abstract

HIV Drug Resistance and HIV Transmission Risk Behaviors Among Active Injection
Drug Users.
Kozal MJ, Amico KR, Chiarella J, et al
J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):106-109.
Abstract

High-Risk Behavior and Potential Transmission of Drug-Resistant HIV Among Injection
Drug Users.
Sethi AK, Celentano DD, Gange SJ, et al
J Acquir Immune Defic Syndr. 2004 Mar 15;35(5):503-510.
Abstract

Human Immunodeficiency Virus Type 1 Superinfection Was Not Detected following
215 Years of Injection Drug User Exposure.
Tsui R, Herring BL, Barbour JD, et al
J Virol. 2004 Jan 1;78(1):94-103.
Abstract

Intersubtype Human Immunodeficiency Virus Type 1 Superinfection following
Seroconversion to Primary Infection in Two Injection Drug Users.
Ramos A, Hu D J, Nguyen L, et al;
J Virol 2002 Aug;76(15):7444-52
Abstract

Conference Reports, Abstracts, and Posters

Risks for sexual diffusion of HIV from IDUs to non-injectors
WA Zule, KS. Riehman, G Bobashev, et al.
(132 APHA)
Abstract

POSTER
The HIV-2 Epidemic May Have Been Sparked by Parenteral Transmission
P Gomes, A Abecasis, M Almeida, et al.
(11 CROI)
PDF Poster Abstract

Testing/Monitoring

Antibody Testing Journal Papers, Abstracts, and Commentaries
	Correlates of HIV Antibody Testing Among a Sample of Injection Drug Users: The Role of Social and Contextual Factors. Tobin KE, Tang AM, Gilbert SH, Latkin CA. AIDS Behav. 2004 Sep;8(3):303 Abstract

Viral Load

Journal Papers, Abstracts, and Commentaries

	Higher Viral Loads and Other Risk Factors Associated With HIV-1 Seroconversion During a Period of High Incidence Among Injection Drug Users in Bangkok. Hu DJ, Subbarao S, Vanichseni S, Mock PA, et al. J Acquir Immune Defic Syndr 2002 Jun 1;30(2):240-247 Abstract

	HIV-1 RNA Viral Load Monitoring in HIV-Infected Drug Users on Antiretroviral Therapy: Relationship With Outpatient Care Patterns Laine C, Zhang D, Hauck WW, Turner BJ. J Acquir Immune Defic Syndr 2002 Mar1;29(3):270-274 Abstract

HIV Sequelae

Anemia

Journal Papers, Abstracts, and Commentaries

Improvement of anemia among HIV-infected injection drug users receiving highly active
antiretroviral therapy.
Semba RD, Shah N, Vlahov D.
J Acquir Immune Defic Syndr 2001 Apr1;26(4):315-9
Abstract

Conference Reports, Abstracts, and Posters

In HIV+ drug users anemia is associated with lower CD4 count,
hospitalization, and emergency room (ER) admissions
S Sales, A Campa, H Timothee, et al
(15IAC)
Abstract

Nutrition/Malnutrition

Journal Papers, Abstracts, and Commentaries

HIV-Related Wasting in HIV-Infected Drug Users in the Era of Highly Active Antiretroviral
Therapy.
Campa A, Yang Z, Lai S, Xue L,
Clin Infect Dis. 2005 Oct 15;41(8):1179-85.
Abstract

Dietary intake and body mass index in HIV-positive and HIV-negative drug abusers of
Hispanic ethnicity.
Forrester JE, Tucker KL, Gorbach SL.et al
Public Health Nutr. 2004 Oct;7(7):863-70.
Abstract

Conference Reports, Abstracts, and Posters

Adequate zinc intake is strongly associated with lower incidence of diarrhea in HIV+
drug users
A Campa, F Huffman, S Sales, et al
(15IAC)
Abstract

Hemodialysis

Journal Papers, Abstracts, and Commentaries

Influence of Intravenous Drug Abuse on Vascular Access Placement and Survival in
HIV-Seropositive Patients.
Eustace JA, Gregory PC, Krishnan M, Ni W, Kuhn DM
Nephron Clin Pract. 2005 Apr 7;100(2):c38-c45
Abstract

Women

Journal Papers, Abstracts, and Commentaries

Substance use and psychotherapeutic medications: A likely contributor to menstrual
disorders in women who are seropositive for human immunodeficiency virus.
Harlow Sn SD, Cohen M, Ohmit SE, et al.
Am J Obstet Gynecol 2003 Apr;188(4):881-6
Abstract

IDU Disease Main Page Main New and Noteworthy Home Page

IDU Health: HIV Clinical Management